Cecilia Johansson

Cecilia Johansson

Auto-generated profile, based on publicly available information

Cecilia Johansson

Respiratory Infections Section, National Heart and Lung Institute, Imperial College London

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MWMichael T. Wilson
Michael T. Wilson
CJCecilia Johansson
Cecilia Johansson
DODanyvid Olivares-Villagómez
Danyvid Olivares-Villagómez
ASAvneesh K. Singh
Avneesh K. Singh
ASAleksandar Stanic-Kostic
Aleksandar Stanic-Kostic
Luc Van KaerLuc Van Kaer
Luc Van Kaer
CD1d-restricted natural killer T (NKT) cells are a subset of regulatory T cells that react with glycolipid antigens. Although preclinical studies have effectively targeted NKT cells for immunotherapy, little is known regarding the earlyin vivoresponse of these cells to antigenic stimulation. We have analyzed the early response of NKT cells to glycolipid antigens and bacterial infection by using specific reagents for tracking these cells. Our results demonstrate dramaticin vivoexpansion and surface phenotype alterations after NKT cell activation with α-galactosylceramide. In addition, we show significant NK1.1 down-modulation on NKT cells in the setting of oralSalmonellainfection. Our results indicate thatin vivoactivation of NKT cells leads to a dynamic response characterized by surface receptor down-modulation and expansion. These findings alter current understanding of NKT cell biology and should aid in the rational design of NKT cell-based immunotherapies.

20 April 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MGMichelle Goritzka
Michelle Goritzka
SMSpyridon Makris
Spyridon Makris
FKFahima Kausar
Fahima Kausar
LDLydia Durant
Lydia Durant
CPCatherine Pereira
Catherine Pereira
CJCecilia Johansson
Cecilia Johansson
Type I interferons (IFNs) are important for host defense from viral infections, acting to restrict viral production in infected cells and to promote antiviral immune responses. However, the type I IFN system has also been associated with severe lung inflammatory disease in response to respiratory syncytial virus (RSV). Which cells produce type I IFNs upon RSV infection and how this directs immune responses to the virus, and potentially results in pathological inflammation, is unclear. Here, we show that alveolar macrophages (AMs) are the major source of type I IFNs upon RSV infection in mice. AMs detect RSV via mitochondrial antiviral signaling protein (MAVS)–coupled retinoic acid–inducible gene 1 (RIG-I)–like receptors (RLRs), and loss of MAVS greatly compromises innate immune restriction of RSV. This is largely attributable to loss of type I IFN–dependent induction of monocyte chemoattractants and subsequent reduced recruitment of inflammatory monocytes (infMo) to the lungs. Notably, the latter have potent antiviral activity and are essential to control infection and lessen disease severity. Thus, infMo recruitment constitutes an important and hitherto underappreciated, cell-extrinsic mechanism of type I IFN–mediated antiviral activity. Dysregulation of this system of host antiviral defense may underlie the development of RSV-induced severe lung inflammation.

8 March 2023 in Nature
Verified
Journal Article
Closed access
PDF file
AHAlexander Hooftman
Alexander Hooftman
CPChristian G. Peace
Christian G. Peace
DRDylan G. Ryan
Dylan G. Ryan
EDEmily A. Day
Emily A. Day
MYMing Yang
Ming Yang
Luke O'NeillLuke O'Neill
Luke O'Neill

26 April 2017 in Annual Review of Immunology
Verified
Journal Article
Closed access
POPeter JM Openshaw
Peter JM Openshaw
CCChris Chiu
Chris Chiu
FCFiona J. Culley
Fiona J. Culley
CJCecilia Johansson
Cecilia Johansson
Respiratory syncytial virus (RSV) is an exceptional mucosal pathogen. It specializes in infection of the ciliated respiratory epithelium, causing disease of variable severity with little or no direct systemic effects. It infects virtually all children by the age of three years and then repeatedly infects throughout life; this it does despite relatively slight variations in antigenicity, apparently by inducing selective immunological amnesia. Inappropriate or dysregulated responses to RSV can be pathogenic, causing disease-enhancing inflammation that contributes to short- and long-term effects. In addition, RSV's importance as a largely unrecognized pathogen of debilitated older people is increasingly evident. Vaccines that induce nonpathogenic protective immunity may soon be available, and it is possible that different vaccines will be optimal for infants; older children; young to middle-age adults (including pregnant women); and elderly persons. At the dawn of RSV vaccination, it is timely to review what is known (and unknown) about immune responses to this fascinating virus.

9 October 2020 in Science
Verified
Journal Article
Closed access
MHMaximillian S. Habibi
Maximillian S. Habibi
RTRyan Thwaites
Ryan Thwaites
MCMeiping Chang
Meiping Chang
AJAgnieszka Jozwik
Agnieszka Jozwik
APAllan Paras
Allan Paras
POPeter JM Openshaw
Peter JM Openshaw
ACHOO!-trophils?: Why some individuals come down with a cold in any given year, whereas others are spared, is poorly understood. Habibi et al. exposed volunteers to respiratory syncytial virus (RSV), one of the pathogens responsible for the common cold, and then followed them over the ensuing 2 weeks (see the Perspective by Mirchandani and Walmsley). The main factor distinguishing the infected from the noninfected was that the former showed signs of airway neutrophil activation before exposure to RSV. Conversely, protected individuals showed enhanced interleukin-17 signaling soon after virus inoculation. Similarly, mice pretreated with a neutrophil chemoattractant were more susceptible to RSV infection and CD8 + T cell–driven disease. Neutrophil proteases, which can modulate cytokine activity, may explain the disparity and could provide therapeutic targets for RSV and other respiratory infections. Science , this issue p. eaba9301 ; see also p. 166

1 March 2012 in Mucosal Immunology
Verified
Journal Article
Open access
JLJ Loebbermann
J Loebbermann
HTH Thornton
H Thornton
LDLydia Durant
Lydia Durant
TST Sparwasser
T Sparwasser
KWK E Webster
K E Webster
POPeter JM Openshaw
Peter JM Openshaw
The inflammatory response to lung infections must be tightly regulated, enabling pathogen elimination while maintaining crucial gas exchange. Using recently described “depletion of regulatory T cell” (DEREG) mice, we found that selective depletion of regulatory T cells (Tregs) during acute respiratory syncytial virus (RSV) infection enhanced viral clearance but increased weight loss, local cytokine and chemokine release, and T-cell activation and cellular influx into the lungs. Conversely, inflammation was decreased when Treg numbers and activity were boosted using interleukin-2 immune complexes. Unexpectedly, lung (but not draining lymph node) Tregs from RSV-infected mice expressed granzyme B (GzmB), and bone marrow chimeric mice with selective loss of GzmB in the Treg compartment displayed markedly enhanced cellular infiltration into the lung after infection. A crucial role for GzmB-expressing Tregs has not hitherto been described in the lung or during acute infections, but may explain the inability of children with perforin/GzmB defects to regulate immune responses to infection. The effects of RSV infection in mice with defective immune regulation closely parallel the observed effects of RSV in children with bronchiolitis, suggesting that the pathogenesis of bronchiolitis may involve an inability to regulate virus-induced inflammation.